Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Data-driven classification of metabolic-associated steatotic liver disease subtypes predicting hepatic and extrahepatic progression. | Chin Med J (Engl) | 2026 | 41603029 | PubTator, text mining | PubMed |
| Genetic Variants in Liver Cirrhosis: Classifications, Mechanisms, and Implications for Clinical Practice. | J Pers Med | 2026 | 41590522 | PubTator, text mining | PubMed |
| A PNPLA3-NACC1-RIPK3 pathway mediates macrophage necroptosis and inflammation in MASLD. | Hepatol Commun | 2026 | 41564367 | PubTator, text mining | PubMed |
| Noninvasive strategies for metabolic dysfunction-associated steatotic liver disease assessment and referral in Japan. | World J Gastroenterol | 2026 | 41551835 | PubTator, text mining | PubMed |
| Low Cholesterol due to APOB Variants: Exploring the Balance Between Liver and Cardiovascular Risk. | Liver Int | 2026 | 41549954 | PubTator, text mining | PubMed |
| Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023. | Diabetes Metab J | 2026 | 41531290 | PubTator, text mining | PubMed |
| PNPLA3 Genotype and Clinical Factors Impact Hepatocellular Carcinoma Risk: Findings From a Prospective Cohort Study. | Aliment Pharmacol Ther | 2026 | 41527281 | PubTator, text mining | PubMed |
| Reply: The PNPLA3 paradox-Does genotype modify the clinical utility of the MASLD framework in children? | Hepatology | 2026 | 41525506 | PubTator, text mining | PubMed |
| The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease. | Ann Hepatol | 2026 | 41520698 | PubTator, text mining | PubMed |
| Linked Intronic Polymorphisms of the PNPLA3 Gene Are Associated with Serum Markers of Liver Injury in Patients with Spontaneous HCV Clearance. | Int J Mol Sci | 2026 | 41516346 | PubTator, text mining | PubMed |
| Integrated Cross-Platform Analysis Reveals Candidate Variants and Linkage Disequilibrium-Defined Loci Associated with Osteoporosis in Korean Postmenopausal Women. | Diagnostics (Basel) | 2026 | 41515648 | PubTator, text mining | PubMed |
| Letter to the Editor: The PNPLA3 paradox-Does genotype modify the clinical utility of the MASLD framework in children? | Hepatology | 2026 | 41512193 | PubTator, text mining | PubMed |
| PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis. | JHEP Rep | 2026 | 41492318 | PubTator, text mining | PubMed |
| Association between PNPLA3 rs738409 and susceptibility to etiology-specific liver cirrhosis: a systematic review and meta-analysis. | BMC Med Genomics | 2026 | 41491174 | PubTator, text mining | PubMed |
| Identification of Circulating MiR-4651 as Novel Biomarker for Metabolic Dysfunction-Associated Steatotic Liver Disease. | Gastro Hep Adv | 2026 | 41487453 | PubTator, text mining | PubMed |
| CMsiRNAdb: a database of chemically modified SiRNA silencing efficiency for nucleic acid drug design. | BMC Bioinformatics | 2026 | 41484819 | PubTator, text mining | PubMed |
| Correlated factors and prognostic importance of reduction in liver stiffness measurement in individuals with type 2 diabetes and MASLD. | Nutr Metab Cardiovasc Dis | 2026 | 41478749 | PubTator, text mining | PubMed |
| YAP/TEAD-activated TAG synthesis and peroxidation in lipid droplets confer ROS resistance in cancer stem cells. | Redox Biol | 2026 | 41385829 | PubTator, text mining | PubMed |
| Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals. | Ann Hepatol | 2026 | 41349715 | PubTator, text mining | PubMed |
| The impact of genetic and environmental risk factors on adverse liver outcomes. | Int J Cancer | 2026 | 41345374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=8